Literature DB >> 17146333

Sonography of the abnormal parathyroid gland.

Aya Kamaya1, Andrew Quon, R Brooke Jeffrey.   

Abstract

In 80% to 90% of patients with primary hyperparathyroidism, a single parathyroid adenoma will be identified as the culprit, whereas the remaining 10% to 20% are caused by multiple adenomas, parathyroid hyperplasia, and rarely, parathyroid carcinoma. At the 2002 National Institute of Health consensus meeting, minimally invasive parathyroidectomy was endorsed as a promising and attractive alternative to total parathyroidectomy. Therefore, preoperative localization of the adenoma is critical in the clinical evaluation of the patient before surgical resection. Although adenomas less than 1 cm may be difficult to visualize sonographically, knowledge of typical imaging characteristics of parathyroid adenomas and use of special sonographic techniques will facilitate identification in most patients. Typical imaging characteristics of parathyroid adenomas include homogeneously hypoechoic echotexture on gray scale with an enlarged feeding artery and peripheral arc of vascularity seen on color and power Doppler. Proper neck extension, unilateral graded compression techniques, and patient swallowing will improve visualization of adenomas.

Entities:  

Mesh:

Year:  2006        PMID: 17146333     DOI: 10.1097/01.ruq.0000237260.33509.4f

Source DB:  PubMed          Journal:  Ultrasound Q        ISSN: 0894-8771            Impact factor:   1.657


  9 in total

1.  Parathyroid-gland ultrasonography in clinical and therapeutic evaluation of renal secondary hyperparathyroidism.

Authors:  C Vulpio; M Bossola; S C Magalini; P Silvestri; G Fadda; M Ciliberti; M L D'Andrea; G Maresca
Journal:  Radiol Med       Date:  2012-10-22       Impact factor: 3.469

2.  Primary hyperparathyroidism: can ultrasonography be the only preoperative diagnostic procedure?

Authors:  S Tresoldi; G Pompili; R Maiolino; N Flor; L De Pasquale; A Bastagli; F Sardanelli; G Cornalba
Journal:  Radiol Med       Date:  2009-09-22       Impact factor: 3.469

3.  Impact of adenoma weight and ectopic location of parathyroid adenoma on localization study results.

Authors:  Yeşim Erbil; Umut Barbaros; Mustafa Tükenmez; Halim Işsever; Artür Salmaslioğlu; Işik Adalet; Selçuk Ozarmağan; Serdar Tezelman
Journal:  World J Surg       Date:  2008-04       Impact factor: 3.352

4.  OCCULT PRIMARY HYPERPARATHYROIDISM: A CASE REPORT AND REVIEW OF PARATHYROID ULTRASONOGRAPHY.

Authors:  Matthew C Moccia; Eli E Miller; Cherie L Vaz
Journal:  AACE Clin Case Rep       Date:  2020-05-11

5.  Needle aspirate PTH in diagnosis of primary hyperparathyroidism due to intrathyroidal parathyroid cyst.

Authors:  Deep Dutta; Chitra Selvan; Manoj Kumar; Saumik Datta; Ram Narayan Das; Sujoy Ghosh; Satinath Mukhopadhyay; Subhankar Chowdhury
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2013-07-01

6.  Huge brown tumor of the rib in an unlocatable hyperparathyroidism patient with "self-recovered" serum calcium and parathyroid hormone: A case report.

Authors:  Wen-Da Wang; Ning Zhang; Qiang Qu; Xiao-Dong He
Journal:  World J Clin Cases       Date:  2019-12-26       Impact factor: 1.337

7.  A retrospective review of the role of B-mode and color Doppler ultrasonography in the investigation of primary hyperparathyroidism: Features that differentiate benign from malignant lesions.

Authors:  Cheng Fang; Eleni Konstantatou; Nicola J Mulholland; Serena Baroncini; Mohammad A Husainy; Klaus-Martin Schulte; Paul S Sidhu
Journal:  Ultrasound       Date:  2018-02-10

8.  Thyroid ultrasonography: pitfalls and techniques.

Authors:  Seon Hyeong Choi; Eun-Kyung Kim; Soo Jin Kim; Jin Young Kwak
Journal:  Korean J Radiol       Date:  2014-03-07       Impact factor: 3.500

9.  Ultrasound elastography score and strain index in different parathyroid lesions.

Authors:  Bekir Cakir; F Neslihan Cuhaci Seyrek; Oya Topaloglu; Didem Ozdemir; Ahmet Dirikoc; Cevdet Aydin; Sefika Burcak Polat; Berna Evranos Ogmen; Ali Abbas Tam; Husniye Baser; Aylin Kilic Yazgan; Mehmet Kilic; Afra Alkan; Reyhan Ersoy
Journal:  Endocr Connect       Date:  2019-12       Impact factor: 3.335

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.